The intersection of real estate and life sciences – PropSci – is a continuously evolving sector that impacts industries and transforms the way we do business globally. Companies within the life sciences industry vertical have a profound impact on innovative real estate ideas and opportunities, and the overlap between these two sectors will continue to shape the future of this space.
As a first-of-its-kind group among leading global law firms, Goodwin’s PropSci practice is positioned at the forefront of both the real estate and life sciences markets with a particularly deep network of cross-sector clients. Our understanding of the unique needs of users for R&D and manufacturing space, as well as the challenges that arise in developing, leasing, acquiring, structuring, financing, owning and operating real estate for life sciences and biotech uses, is unparalleled. We are a long-term partner to our clients, representing life sciences companies at all stages of their corporate life cycle and guiding real estate investors through all aspects of owning and operating laboratory, biomanufacturing and other life sciences facilities.
Goodwin’s PropSci practice is an extensive, global network of nearly 300 life sciences and real estate lawyers facing the market. Whether advising companies on pre-Series A financing through exits via IPOs and acquisitions, construction and financing of life sciences facilities, or leasing transactions, our PropSci practice works seamlessly to advise companies and investors across all stages and multiple business needs.